Browse the evidence

Only 2 out of 41 studies (approximately 5%) reported or assessed dietary intake or evaluated diet changes secondary to GLP-1/GIP RA medication use.

Practitioners should be aware of the lack of dietary assessment in studies involving GLP-1/GIP medications.

The quality of dietary assessment methods used in the studies was categorized as 'poor' and 'acceptable'.

Practitioners should consider the quality of dietary assessment methods when interpreting study results.

The review highlights a major gap in the evidence requiring urgent attention for high-quality research on dietary impacts of GLP-1/GIP medications.

There is a critical need for more rigorous studies to assess dietary changes associated with these medications.

Patients identified three risks associated with obesity treatment.

Understanding these risks can help healthcare providers address patient concerns and improve treatment uptake.

The uptake of obesity treatments remains disproportionally low in people living with the disease.

Healthcare providers should be aware of the low uptake to better engage patients in treatment options.

Consensus recommendations for safe practices in bariatric and metabolic surgery tourism (BMT) were established by healthcare professionals and patient representatives across Europe.

Healthcare providers should adhere to the established consensus recommendations for BMT.

Further evaluation is required regarding outcomes following bariatric and metabolic surgery tourism.

Ongoing research is essential to assess the effectiveness and safety of BMT practices.

The intervention subjects lost more weight than the control subjects (-4.1 kg vs -2.1 kg), but the difference was not statistically significant (p = 0.22).

Practitioners may consider remote dietitian support for weight loss in patients before joint surgery.

The intervention subjects had higher odds of achieving a BMI of <40 kg/m 2 (odds ratio = 1.9), but this was not statistically significant (p = 0.44).

Practitioners may find that remote interventions can help some patients achieve a healthier BMI before surgery.

Obesity is a chronic multifactorial disease.

Understanding obesity as a multifactorial disease is crucial for effective treatment.

There has been limited success in curbing the incidence of T2D despite lifestyle modification being standard care.

Practitioners should recognize the barriers to effective lifestyle interventions.

The current evidence is insufficient to establish ingestion recommendations for protein hydrolysate supplementation.

Practitioners should be cautious in making specific recommendations for protein hydrolysate intake until more evidence is available.

The incidence of type 2 diabetes among non-operated patients with obesity was 11.7% during the follow-up period.

Non-operated obese patients have a high incidence of type 2 diabetes, highlighting the need for effective interventions.

The incidence of type 2 diabetes among gastric bypass patients was comparable to that of the general population.

Gastric bypass surgery can reduce diabetes risk to levels similar to those in the general population, indicating its effectiveness.

The study utilized a 2-way ANOVA with Tukey’s post hoc comparison to evaluate differences between groups.

The statistical methods indicate a rigorous approach to analyzing the data.

No significant changes were found in body mass (BM) between linear training (LT) and undulating periodization (UP) groups after 8 weeks.

Both training protocols did not lead to significant changes in body mass for untrained older adults.

No significant changes were found in fat mass (FM) between linear training (LT) and undulating periodization (UP) groups after 8 weeks.

Both training protocols did not lead to significant changes in fat mass for untrained older adults.

No significant changes were found in fat-free mass (FFM) between linear training (LT) and undulating periodization (UP) groups after 8 weeks.

Both training protocols did not lead to significant changes in fat-free mass for untrained older adults.

PA may not be a critical factor influencing weight maintenance in PWD.

Weight maintenance strategies for PWD may need to consider factors beyond just physical activity.

Alabama participants had more favorable scores for hedonic eating at baseline and maintained these scores at week 16 compared to Colorado participants.

Understanding hedonic eating can help tailor interventions to improve weight loss outcomes.

The three evaluated accelerometers provided estimates of total energy expenditure (TEE) differing significantly from TEE measured by doubly labeled water (DLW), with differences ranging from -690 to 220 kcal/d.

Practitioners should be cautious when using these accelerometers for TEE estimation as they may not provide fully accurate results.

Regression equations generated from accelerometer-assessed TEE accounted for 46-74% of the variability in DLW-measured TEE.

The accelerometers can provide a reasonable estimate of TEE variability, but should be used with caution.

Habitual sleep duration did not alter overfeeding-mediated body weight gain, fat gain, and fat distribution.

Sleep duration may not influence weight or fat gain during overfeeding.

The evidence supporting GLP-1RAs for treating PsO and PsA remains limited.

Further clinical research is needed to establish the efficacy and safety of GLP-1RAs for PsO and PsA.